Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
about
Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell lineMeta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulationA shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.The relationship between prognostic and predictive factors in the management of breast cancer.IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of ChinaBiologic markers determine both the risk and the timing of recurrence in breast cancer.Hormone-receptor expression and survival patterns in operated cases of female invasive ductal breast carcinoma in Kerala: a retrospective cohort study.p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.Personality Disorders, Narcotics, and Stimulants; Relationship in Iranian Male Substance Dependents PopulationPrimary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index.A candidate molecular signature associated with tamoxifen failure in primary breast cancerAndrogen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.Canine mammary tumours, an overview.Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.Histopathological data.Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.A semiparametric approach for the two-sample comparison of survival times with long-term survivors.Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women.Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive years.Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases.Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.Estrogen receptors: role in breast cancer.Canine mammary tumors as a model for human disease.
P2860
Q24546317-CD8F962E-C44F-4628-9AA0-E741C7E224D6Q33316875-77AF63E8-D6CE-4589-8E98-920913FF761DQ33483295-3B589C3F-E39A-484D-AF05-20AC860CAD7BQ33538455-CCD5A1E8-D75D-4B84-9461-07E0D3DBD6FAQ33662031-30B3607F-8B1A-45F2-83DD-B6800B4DC7FEQ34609703-ADA5915C-CA61-4167-B8E1-567CA9E73A43Q35073921-9093E0A3-9129-4705-8ABA-74751F8DA721Q35537892-1EE4DF5E-0BFB-4BBD-9990-B50057C1F98BQ35633721-67664567-D21B-4D90-A328-12BA8CF6D50DQ35749359-95104C20-35B1-4E7E-BA40-49E0194A0623Q35872734-6DBA41CA-5BDF-4D2A-B57E-581BFB80B4E2Q35909551-27C2D302-D6B4-4CAA-AD1B-516F6261D788Q35954421-FC73D2E9-FE7E-4EDF-A4BF-C7CB4D2230CBQ35964928-480920BA-36DC-4D91-AB91-8DDECEB4FF49Q36006169-141BC5BE-3877-4D11-A837-F1CAC00428ECQ36431261-D3F6D35A-6863-412F-B2DE-FFA0D4E9610DQ36617900-0BDD1F63-A6C3-486A-BDAE-FD66085BEC4DQ36619003-ABF631EB-3047-415A-8DBB-BFB73E24964FQ36619429-65048344-F51C-4392-9188-E6C07513D70EQ36624255-B74B115A-528E-4F5E-AAF3-3986DA6E2F79Q37038692-B3BE67CE-8A6F-4616-909B-3CAF7E5A518DQ37074119-4947639C-566F-4CFE-A74B-D534854CE588Q37885436-316BB940-E2BD-40FB-95D6-62614B227043Q38484122-E525D6BE-B72C-4836-B7F6-0266C5A0196CQ40171629-80EC8E48-5743-475F-85E4-51F2AD7144FFQ43001639-AFD5E2D9-96F0-475C-85CF-3C6B0256F53AQ43202265-FA594CE1-6B8E-43D2-9B3F-E6564F6F8DD5Q43733218-9E3E91B7-E3C6-4134-B941-321D6419D882Q44702488-C0B8F512-3778-4C65-BE79-C5081B1F529AQ45154462-2771F284-0557-4D5F-8A31-E652855ED94BQ45714418-2C6AE031-73D6-41DE-BD57-5B64598D84DBQ46482162-D8473063-AB2D-4F62-B854-1DA808DCD9ADQ46827610-25312F5F-4C24-4542-9B8F-2B6E07B4C90FQ47205691-3D72BFAA-A3A9-4DBA-9AC0-41FA8D2B9C4BQ51772667-53452213-D318-473F-B536-50FF0776121AQ52234534-7FFE3DA8-3D79-4D57-AC64-5962F1268E7DQ53595317-57214AE9-CDDB-4409-847A-6BC3CDAFAF10Q55368630-173686AA-40FF-49E0-948E-DDBAA6B5129A
P2860
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Prognostic value of steroid re ...... 2257 operable breast cancers.
@ast
Prognostic value of steroid re ...... 2257 operable breast cancers.
@en
type
label
Prognostic value of steroid re ...... 2257 operable breast cancers.
@ast
Prognostic value of steroid re ...... 2257 operable breast cancers.
@en
prefLabel
Prognostic value of steroid re ...... 2257 operable breast cancers.
@ast
Prognostic value of steroid re ...... 2257 operable breast cancers.
@en
P2093
P2860
P356
P1476
Prognostic value of steroid re ...... 2257 operable breast cancers.
@en
P2093
Asselain B
Basuyau JP
Courriere P
Delarue JC
Magdelenat H
P2860
P2888
P304
P356
10.1038/BJC.1996.291
P407
P577
1996-06-01T00:00:00Z